Cargando…

Liver fibrosis progression in a cohort of young HIV and HIV/ HBV co-infected patients: A longitudinal study using non-invasive APRI and Fib-4 scores

BACKGROUND: The risk of liver fibrosis increases over time in HIV and HIV-HBV individuals even under antiretroviral treatment (ART), warranting a rigorous and periodic monitorization. Given the lower availability of transient elastography, we aimed to assess the longitudinal variation of two non-inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iacob, Diana Gabriela, Luminos, Monica, Benea, Otilia Elisabeta, Tudor, Ana-Maria, Olariu, Cristina Mihaela, Iacob, Simona Alexandra, Ruta, Simona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372617/ https://www.ncbi.nlm.nih.gov/pubmed/35966860 http://dx.doi.org/10.3389/fmed.2022.888050

Ejemplares similares

APRI and FIB-4 scores are not associated with neurocognitive impairment in HIV-infected persons
por: Libertone, Raffaella, et al.
Publicado: (2014)

Liver fibrosis: concordance analysis between APRI and FIB-4 scores, evolution and predictors in a cohort of HIV patients without HCV and HBV infection
por: Mendeni, M, et al.
Publicado: (2010)

HIV-HBV Coinfection—Current Challenges for Virologic Monitoring
por: Ruta, Simona, et al.
Publicado: (2023)

Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown
por: Iacob, Simona Alexandra, et al.
Publicado: (2022)

Muco-cutaneous manifestations in HIV infection/AIDS
por: Benea, Vasile, et al.
Publicado: (2014)

Intestinal Microbiota as a Host Defense Mechanism to Infectious Threats
por: Iacob, Simona, et al.
Publicado: (2019)

APRI and FIB-4 indices as diagnostic noninvasive scores for prediction of severe fibrosis in patients with biliary atresia
por: Nagi, Salma Abdel Megeed, et al.
Publicado: (2023)

Prognostic accuracy of FIB‐4, NAFLD fibrosis score and APRI for NAFLD‐related events: A systematic review
por: Lee, Jenny, et al.
Publicado: (2021)

Diagnostic performance of APRI and FIB-4 for confirming cirrhosis in Indonesian HIV/HCV co-infected patients
por: Yunihastuti, Evy, et al.
Publicado: (2020)

Eosinophilic Colitis and Clostridioides difficile Sepsis With Rapid Remission After Antimicrobial Treatment; A Rare Coincidence and Its Pathogenic Implications
por: Iacob, Simona Alexandra, et al.
Publicado: (2020)

Liver fibrosis staging with combination of APRI and FIB-4 scoring systems in chronic hepatitis C as an alternative to transient elastography
por: Papadopoulos, Nikolaos, et al.
Publicado: (2019)

FIB-4 and APRI scores for predicting severe liver fibrosis in chronic hepatitis HCV patients: a monocentric retrospective study
por: Catanzaro, Roberto, et al.
Publicado: (2021)

Circulating microRNAs as non-invasive biomarkers for hepatitis B virus liver fibrosis
por: Iacob, Diana Gabriela, et al.
Publicado: (2020)

APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level
por: Yen, Yi-Hao, et al.
Publicado: (2018)

The liver fibrosis index is superior to the APRI and FIB-4 for predicting liver fibrosis in chronic hepatitis B patients in China
por: Huang, Dedong, et al.
Publicado: (2019)

Evaluation of NAFLD fibrosis, FIB-4 and APRI score in diabetic patients receiving exenatide treatment for non-alcoholic fatty liver disease
por: Unsal, İlknur Ozturk, et al.
Publicado: (2022)

Advantages of a Novel Model for Predicting Hepatic Fibrosis in Chronic Hepatitis B Virus Carriers Compared with APRI and FIB-4 Scores
por: Kang, Na-Ling, et al.
Publicado: (2022)

Ibalizumab Targeting CD4 Receptors, An Emerging Molecule in HIV Therapy
por: Iacob, Simona A., et al.
Publicado: (2017)

Are HIV, HBV and HCV Voluntary Counseling and Testing Programs Needed in Balkans?
por: Sultana, Camelia, et al.
Publicado: (2018)

Impact of age on the diagnostic performances and cut-offs of APRI and FIB-4 for significant fibrosis and cirrhosis in chronic hepatitis B
por: Li, Qiang, et al.
Publicado: (2017)

Difficulties in controlling HIV and TB infections in multi-experienced patients
por: Benea, Șerban, et al.
Publicado: (2014)

Gamma-glutamyl-transpeptidase to platelet ratio is not superior to APRI,FIB-4 and RPR for diagnosing liver fibrosis in CHB patients in China
por: Huang, Rui, et al.
Publicado: (2017)

APRI and FIB-4 performance to assess liver fibrosis against predefined Fibroscan values in chronic hepatitis C virus infection
por: Rungta, Sumit, et al.
Publicado: (2021)

Improving the Adherence to Antiretroviral Therapy, a Difficult but Essential Task for a Successful HIV Treatment—Clinical Points of View and Practical Considerations
por: Iacob, Simona A., et al.
Publicado: (2017)

Fibroscan Compared to FIB-4, APRI, and AST/ALT Ratio for Assessment of Liver Fibrosis in Saudi Patients With Nonalcoholic Fatty Liver Disease
por: Fallatah, Hind I., et al.
Publicado: (2016)

Substantial concordance between transient elastography and APRI and FIB-4 combination amongst hepatitis C inmates with non advanced liver fibrosis
por: Yela, E, et al.
Publicado: (2022)

Diagnostic Accuracy of APRI, AAR, FIB-4, FI, and King Scores for Diagnosis of Esophageal Varices in Liver Cirrhosis: A Retrospective Study
por: Deng, Han, et al.
Publicado: (2015)

Concordance between noninvasive assessments of fibrosis in patients with HIV/HIV+HBV infection
por: Dumea, Elena, et al.
Publicado: (2014)

Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis
por: Iacob, Simona, et al.
Publicado: (2019)

SARS-CoV-2 Treatment Approaches: Numerous Options, No Certainty for a Versatile Virus
por: Iacob, Simona, et al.
Publicado: (2020)

Dynamics of APRI and FIB-4 in HCV cirrhotic patients who achieved SVR after DAA therapy
por: Leuştean, Anca, et al.
Publicado: (2021)

Evaluation of hepatic fibrosis in HIV/HCV co-infected individuals in Yaoundé, Cameroon: usefulness of APRI score in resource-constrained settings
por: Dobseu, Rodolphe, et al.
Publicado: (2020)

Identification and external validation of the optimal FIB‐4 and APRI thresholds for ruling in chronic hepatitis B related liver fibrosis in tertiary care settings
por: Liu, Kecheng, et al.
Publicado: (2020)

Pulmonary, ocular and cutaneous Kaposi sarcoma in a HIV-infected patient
por: Ionică, Mihaela, et al.
Publicado: (2014)

Aspartate transaminase to platelet ratio index (APRI) but not FIB-5 or FIB-4 is accurate in ruling out significant fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) in an urban slum-dwelling population
por: Kolhe, Kailash Marotrao, et al.
Publicado: (2019)

APRI Score as a Predictor of Significant Liver Fibrosis in Chronic Hepatitis B
por: Ayed, Houda Ben, et al.
Publicado: (2017)

Cryptococcosis in a patient with HIV infection
por: Benea, Vasile, et al.
Publicado: (2013)

A Comparative Analysis of the APRI, FIB4, and FibroScan Score in Evaluating the Severity of Chronic Liver Disease in Chronic Hepatitis B Patients in India
por: Rungta, Sumit, et al.
Publicado: (2021)

The Score Model Containing Chinese Medicine Syndrome Element of Blood Stasis Presented a Better Performance Compared to APRI and FIB-4 in Diagnosing Advanced Fibrosis in Patients with Chronic Hepatitis B
por: Chi, Xiao-Ling, et al.
Publicado: (2016)

ALBI/ST ratio versus FIB-4 and APRI as a predictor of posthepatectomy liver failure in hepatocellular carcinoma patients
por: Zhang, Ze-Qun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cl5aq8d6kr45l8kn117g8454f4